The role of the risk gene CACNA1C in neuroinflammation and peripheral immunity in autism spectrum disorder.

This review looks at how a specific gene called CACNA1C, which is linked to autism risk, affects the immune system. This gene makes calcium channels that help brain cells communicate and also influence immune cells throughout the body. The researchers discuss how problems with these channels might contribute to inflammation in autism and suggest they could be targets for new treatments.

This review examines the role of the CACNA1C gene, a major genetic risk factor for autism spectrum disorder (ASD), in immune dysfunction and neuroinflammation. CACNA1C encodes the Ca1.2 calcium channel, which regulates neuronal functions essential for brain development and also influences immune cell activation in both the central nervous system (microglia) and peripheral immune system (T cells, B cells, dendritic cells). The review synthesizes current knowledge on how Ca1.2 channels contribute to immune dysregulation in ASD and explores the therapeutic potential of targeting these channels to address both behavioral symptoms and inflammatory conditions associated with autism.

The identification of CACNA1C/Ca1.2 channels as key players in both neuronal function and immune regulation provides a mechanistic link between genetic risk and immune dysfunction in autism. This offers potential for developing targeted therapies that could address both core autism symptoms and associated inflammatory conditions.

As a review article, this study does not present new experimental data. The specific role of Ca1.2 in immune regulation and neuroinflammation in ASD remains to be fully elucidated, indicating gaps in current understanding.

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by persistent deficits in social communication and interaction, restricted and repetitive behaviors and interests, with the severity of symptoms varying greatly among individuals. The pathogenesis of ASD is influenced by the complex interaction of genetic and environmental factors. Increasing evidence suggests that dysregulated immune processes represent a crucial aspect in ASD pathology. The CACNA1C gene, which encodes the pore-forming α1C subunit of the L-type calcium channel (LTCC) Ca1.2, is a major genetic risk factor for ASD.

Ca1.2 channels modulate neuronal excitability, synaptic plasticity, and neurotransmitter release in the central nervous system (CNS), all of which are essential for brain development and function. Ca1.2 channels are also expressed in generally non-excitable immune cells, including CNS microglia and peripheral immune cells, where they influence activation, differentiation, and cytokine release. These immune functions may contribute to ASD pathogenesis; however, the specific role of Ca1.2 in immune regulation and neuroinflammation in ASD is yet to be elucidated. Here, we will review recent research on the role of CACNA1C in immune mechanisms relevant to ASD.

We will summarize current knowledge on the function of Ca1.2 in brain microglia and peripheral immune cells such as T cells, B cells, and dendritic cells that contribute to immune dysfunction in ASD. In addition, we will discuss the therapeutic prospects of targeting Ca1.2 channels in immune cells to manage both behavioral and inflammatory conditions associated with ASD.